Infrequency of MDM2 Gene Amplification in Pediatric Solid Tumors and Lack of Association with p53 Mutations in Adult Squamous Cell Carcinomas

Cancer Research

Volumn 53, Issue 24, 1993, Pages 6028-6030

  Waber, Pamela G ^a   Chen, Jun ^a   Nisen, Perry D ^b  

^a University of Texas Southwestern Medical Center ^*

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER LOCALIZATION; CARCINOGENESIS; CHILDHOOD CANCER; CONTROLLED STUDY; GENE AMPLIFICATION; GENE EXPRESSION; HEPATOBLASTOMA; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MESOBLASTIC NEPHROMA; NEPHROBLASTOMA; NEUROBLASTOMA; OSTEOSARCOMA; POINT MUTATION; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SOLID TUMOR; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ADULT; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CHILD; GENE AMPLIFICATION; GENES, P53; HUMAN; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASM PROTEINS; NEOPLASMS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027136159     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Fakharzadeh, S. Trusko, S. and George, D. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J. 10: 1565-1569, 1991.
2. Oliner, J. Kinzler, K. Meltzer, P. George, D. and Vogelstein, B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature (Lond.), 358: 80-83, 1992.
3. Momand, J. Zambetti, G. Olson, D. George, D. and Levine, A. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated trans-activation. Cell, 69: 1237-1245, 1992.
4. Oliner, J. Pietenpol, J. Thiagalingam, S. Gyuris, J. Kinzler, K. and Vogelstein, B. Oncoprotein MDM2 conceals the activation domain of tumor suppressor p53. Nature (Lond.), 362: 857-860, 1993.
5. Finlay, C. The MDM2 oncogene can overcome wild-type p53 suppression of transformed cell growth. Mol. Cell. Biol. 13: 301-306, 1993.
6. Ladanyi, M. Cha, C. Lewis, R. Jhanwar, S. Huvos, A. and Jealey, J. MDM2 gene amplification in metastatic osteosarcoma. Cancer Res. 53: 16-18, 1993.
7. Leach, F. Tokino, T. Meltzer, P. Burrell, M. Oliner, J. Smith, S. Hill, D. Sindran-sky, D. Kinzler, K. and Vogelstein, B. p53 mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res. 53: 2231-2234, 1993.
8. Reifenberger, G. Liu, L. Ichimura, K. Schmidt, E. and Collins, V. Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res. 53: 2736-2739, 1993.
9. Felix, C. A. Chavez Kappel, C. Mitsudomi, T. Nau, M. M. Tsokos, M. Crouch, G. D. Nisen, P. D. Winick, N. J. and Helman, L. J. Frequency and diversity of p53 mutations in childhood rhabdomyosarcoma. Cancer Res. 52: 2243-2247, 1992.
10. Ueda, Y. Dockhorn-Dworniczak, B. Blasius, S. Mellin, W. Wuisman, P. Bocker, W. and Roessner, A. Analysis of mutant p53 protein in osteosarcomas and other malignant and benign lesions of bone. J. Cancer Res. Clin. Oncol. 119: 172-178, 1993.
11. Toguchida, J. Yamaguchi, T. Ritchie, B. Beauchamp, R. Dayton, S. Herrera, G. Yamamuro, T. Kotoura, Y. Sasaki, M. Little, J. et al. Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Cancer Res. 52: 6194-9199, 1992.
12. Waber, P. Chen, J. and Nisen, P. D. Infrequency of ras, p53, WT1 or RB gene alterations in Wilms tumor. Cancer (Phila.), in press, 1993.
13. Kohl, N. Kanda, N. Schreck, R. Bruns, G. Latt, S. Gilbert, F. and Alt, F. Transposition and amplification of oncogene-related sequences in human neuroblastomas. Science (Washington DC), 35: 359-367, 1983.
14. Nisen, P. D. Waber, P. Rich, M. Pierce, S. Garvin, J. Gilbert, F. and Lanzkowsky, P. N-myc oncogene RNA expression in neuroblastoma. J. Natl. Cancer Inst. 80: 1633-1637, 1988.
15. Lee, N. K. Ye, Y.-W. Chen, J. Li, X. Waber, P. and Nisen, P. D. P53, RB and HPV in squamous cell carcinoma and adjacent normal mucosa of the upper aerodigestive tract. Arch. Otolaryngol. 119: 1125-1131, 1993.
16. Nisen, P. D. Zimmerman, K. Cotter, S. Gilbert, F. and Alt, F. Enhanced expression of the N-myc gene in Wilms' tumors. Cancer Res. 46: 6217-6222, 1986.
17. D'Amico, D. Carbone, D. Mitsudomi, T. et al. High frequency of somatically acquired p53 mutations in small cell lung carcinoma cell lines and tumors. Oncogene, 7: 339-346, 1992.
18. Hollstein, M. Sidransky, D. Vogelstein, B. and Harris, C. C. p53 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991.